These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22768888)

  • 21. Clinically significant disagreement between mean blood glucose and estimated average glucose in two populations: implications for diabetes management.
    Chalew SA; Hempe JM; McCarter R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1128-35. PubMed ID: 20144426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study.
    Petersson J; Åkesson K; Sundberg F; Särnblad S
    Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications.
    Zhang L; Sun XX; Tian QS
    Acta Diabetol; 2024 Jun; 61(6):679-692. PubMed ID: 38467807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetes; 2010 Jul; 59(7):1585-90. PubMed ID: 20424232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level.
    Ladyzynski P; Foltynski P; Bak MI; Sabalinska S; Krzymien J; Kawiak J
    J Transl Med; 2014 Dec; 12():328. PubMed ID: 25491199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
    Fabris C; Heinemann L; Beck R; Cobelli C; Kovatchev B
    Diabetes Technol Ther; 2020 Jul; 22(7):501-508. PubMed ID: 32459124
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of HbA1c in clinical practice: New insights.
    Bloomgarden Z
    J Diabetes; 2021 Apr; 13(4):280-281. PubMed ID: 33427383
    [No Abstract]   [Full Text] [Related]  

  • 34. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
    Heinemann L; Freckmann G; Müller-Wieland D; Kellerer M
    J Diabetes Sci Technol; 2020 Sep; 14(5):922-927. PubMed ID: 31675907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobin A1c and chronic complications.
    Huang IC; Wang PW; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh CJ
    Chang Gung Med J; 2012; 35(1):46-53. PubMed ID: 22483427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.
    Hermanns N; Schumann B; Kulzer B; Haak T
    J Diabetes Sci Technol; 2014 May; 8(3):516-22. PubMed ID: 24876615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
    Guelho D; Paiva I; Batista C; Barros L; Carrilho F
    Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.